אולנזפין ODT טבע ® 10 מ"ג

País: Israel

Língua: hebraico

Origem: Ministry of Health

Ingredientes ativos:

OLANZAPINE 10 MG

Disponível em:

SALOMON,LEVIN & ELSTEIN LTD

Código ATC:

N05AH03

Forma farmacêutica:

TABLETS ORODISPERSIBLE

Via de administração:

PER OS

Fabricado por:

TEVA OPERATIONS POLAND SP.ZO.O

Grupo terapêutico:

OLANZAPINE

Indicações terapêuticas:

Acute and maintenance treatment of schizophrenia. Olanzapine ODT Teva is indicated for the management of the manifestations of psychotic disorders. Olanzapine ODT Teva is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder. Prevention of recurrence in Bipolar Disorder : In patients whose manic episode has responded to olanzapine treatment Olanzapine ODT Teva is indicated for the prevention of recurrence in patients with Bipolar Disorder. Combination therapy in Bipolar I Disorder: The combination of Olanzapine ODT Teva with lithium or valproate is indicated for the short-term treatment of acute manic episodes associated with Bipolar I Disorder.

Data de autorização:

2011-05-01